E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 7/1/2005 in the Prospect News Biotech Daily.

Momenta Pharmaceuticals files $125 million stock shelf

New York, July 1 - Momenta Pharmaceuticals, Inc. filed a $125 million stock shelf with the Securities and Exchange Commission Friday.

The Cambridge, Mass., biotechnology company will use proceeds for general corporate purposes.

Momenta specializes in analyzing and designing complex sugars to improve existing drugs, develop new drugs and discover new biological processes.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.